Failure-To-Update Claim In Acne Drug Case Was Flawed, 10th Circuit Rules

(July 17, 2017, 1:29 PM EDT) -- DENVER — The 10th Circuit U.S. Court of Appeals on July 13 affirmed a trial court’s dismissal of a pro se plaintiff’s Amnesteem (isotretinoin) injury lawsuit, saying she failed to adequately plead her claim that the drug’s warning label was out of date (Carmen Naomi Watson v. Mylan Pharmaceuticals, Inc., Nos. 16-3349 and 17-3019, 10th Cir., 2017 U.S. App. LEXIS 12529)....

Attached Documents

Related Sections